[Tubo-ovarian actinomycosis, intrauterine device and chemotherapy for breast cancer].
Tubo-ovarian actinomycosis was observed after chemotherapy for breast cancer in a patient with an intrauterine device. Does chemotherapy increase the risk? How can it be prevented?
Salvat
J
J
Service de Gynécologie-Obstétrique, Centre Hospitalier, Thonon.
Slamani
L
L
Knopf
J F
JF
Nicora
C
C
D000196:Actinomycosis / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D005184:Fallopian Tube Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007434:Intrauterine Devices; D008875:Middle Aged; D010049:Ovarian Diseases / Q000139:chemically induced*
D000970:Antineoplastic Agents